Khiron Life Sciences Corp. (KHRNF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Apr 30, 2025
Khiron Life Sciences Company Description
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe.
It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis.
It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru.
Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Khiron Life Sciences Corp.
Country | Canada |
Founded | 2012 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
CEO | Alvaro Torres |
Contact Details
Address: 500 Burrard Street Vancouver, British Columbia British Columbia Canada | |
Phone | 647 556-5750 |
Website | khiron.ca |
Stock Details
Ticker Symbol | KHRNF |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | CAD |
ISIN Number | CA49374L3065 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Dr. Alvaro Francisco Torres | Co-Founder, Chief Executive Officer and Director |
Franziska Katterbach | President of Khiron Europe |
Swapan Kakumanu ACA, ACWA, CGA | Corporate Secretary |
Michael John O'Connor MA | Chief Financial Officer |
Marco Algorta | Country Manager of Uruguay |